SEK 2.64
(-1.49%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 19.05 Million SEK | 90.83% |
2022 | 9.98 Million SEK | -7.04% |
2021 | 10.73 Million SEK | 18.45% |
2020 | 9.06 Million SEK | 11.67% |
2019 | 8.11 Million SEK | -11.09% |
2018 | 9.13 Million SEK | -3.76% |
2017 | 9.48 Million SEK | 24.69% |
2016 | 7.61 Million SEK | 18.62% |
2015 | 6.41 Million SEK | 135.73% |
2014 | 2.72 Million SEK | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 17.43 Million SEK | -8.48% |
2024 Q2 | 15.6 Million SEK | -10.48% |
2023 Q3 | 18.33 Million SEK | 5.76% |
2023 Q2 | 17.33 Million SEK | -0.84% |
2023 Q1 | 17.47 Million SEK | 75.07% |
2023 FY | 19.05 Million SEK | 90.83% |
2023 Q4 | 19.05 Million SEK | 3.93% |
2022 Q3 | 9.6 Million SEK | -3.78% |
2022 Q1 | 10.24 Million SEK | -4.64% |
2022 Q2 | 9.98 Million SEK | -2.54% |
2022 Q4 | 9.98 Million SEK | 3.95% |
2022 FY | 9.98 Million SEK | -7.04% |
2021 Q1 | 9.5 Million SEK | 4.8% |
2021 FY | 10.73 Million SEK | 18.45% |
2021 Q3 | 9.32 Million SEK | -9.13% |
2021 Q4 | 10.73 Million SEK | 15.16% |
2021 Q2 | 10.26 Million SEK | 8.01% |
2020 Q1 | 9 Million SEK | 10.89% |
2020 FY | 9.06 Million SEK | 11.67% |
2020 Q2 | 8.96 Million SEK | -0.46% |
2020 Q3 | 8.5 Million SEK | -5.12% |
2020 Q4 | 9.06 Million SEK | 6.62% |
2019 Q3 | 8.9 Million SEK | -10.34% |
2019 Q1 | 8.76 Million SEK | -4.01% |
2019 Q4 | 8.11 Million SEK | -8.77% |
2019 Q2 | 9.92 Million SEK | 13.23% |
2019 FY | 8.11 Million SEK | -11.09% |
2018 Q2 | 8.78 Million SEK | -17.71% |
2018 FY | 9.13 Million SEK | -3.76% |
2018 Q4 | 9.13 Million SEK | 10.15% |
2018 Q3 | 8.29 Million SEK | -5.61% |
2018 Q1 | 10.67 Million SEK | 12.49% |
2017 Q1 | 7.58 Million SEK | -0.34% |
2017 FY | 9.48 Million SEK | 24.69% |
2017 Q4 | 9.48 Million SEK | 12.94% |
2017 Q3 | 8.4 Million SEK | -41.98% |
2017 Q2 | 14.48 Million SEK | 90.94% |
2016 FY | 7.61 Million SEK | 18.62% |
2016 Q4 | 7.61 Million SEK | 3.61% |
2016 Q3 | 7.34 Million SEK | -59.19% |
2016 Q2 | 18 Million SEK | 93.82% |
2016 Q1 | 9.28 Million SEK | 44.76% |
2015 FY | 6.41 Million SEK | 135.73% |
2015 Q4 | 6.41 Million SEK | 23.83% |
2015 Q3 | 5.18 Million SEK | -18.74% |
2015 Q2 | 6.37 Million SEK | 0.0% |
2015 Q1 | - SEK | -100.0% |
2014 FY | 2.72 Million SEK | 0.0% |
2014 Q4 | 2.72 Million SEK | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Aino Health AB (publ) | 14.36 Million SEK | -32.628% |
Bonzun AB (publ) | 6.95 Million SEK | -174.129% |
Medhelp Care Aktiebolag (publ) | 36.98 Million SEK | 48.489% |
RaySearch Laboratories AB (publ) | 1.21 Billion SEK | 98.435% |
Surgical Science Sweden AB (publ) | 357.46 Million SEK | 94.67% |